ARHS vs EXAS · P/E 14, rev $699.2M vs rev $2.76B
Arhaus Inc (ARHS) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Arhaus Inc (ARHS) is a specialty retail company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported ARHS revenue for 2026-06-30 was $699.2M. Net income was $41.9M. ARHS currently screens at market cap $924.3M and trailing P/E 13.9.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
ARHS currently screens at market cap $924.3M and trailing P/E 13.9. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the ARHS and EXAS stock pages for the full models.
Not investment advice.